Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia

被引:21
|
作者
Kövesi, G
Szende, B
机构
[1] Semmelweis Univ, Dept Periodontol, Fac Dent, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Fac Med, Dept Pathol & Expt Canc Res 1, MTA SE EKSZ Mol Pathol Res Grp, H-1085 Budapest, Hungary
关键词
cyclin D1; leukoplakia; p27; p63;
D O I
10.1111/j.1600-0714.2006.00396.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: Studies on the expression of genes regulating cell proliferation and apoptosis are essential to help better understand the severity and possible malignant transformation of oral leukoplakia. METHODS: The characteristics of cyclin D 1, p27, and p63 were investigated in this microscopic study, complementing our previous results with Ki67, p53, and the apoptosis index. Clinical and histologic as well as immunohistochemical studies were carried out on oral leukoplakia of 18 patients. Homogenous, or non-homogenous (nodular or speckled) and erythroleukoplakia were determined clinically. Pathologic classification was performed according to the degree of dysplasia. Immunoperoxidase reaction for cyclin D I, p27, and p63 was carried out on the biopsy specimens and the positivity of the reactions was calculated for 1000 epithelial cells. RESULTS: The expression of cyclin D I increased in parallel with the severity of leukoplakia. The p27 index was 14-16% in homogenous and nodular leukoplakias but it was substantially lower to 1-2% in erythroleukoplakia. The p63 index was 10% in homogenous, 5% in nodular or speckled, but nearly 20% in erythroleukoplakia, on the average. CONCLUSION: These results suggest that the characteristic expression of cyclin D I, p27, and p63 in various forms of leukoplakia may be of prognostic value.
引用
收藏
页码:274 / 277
页数:4
相关论文
共 50 条
  • [21] Alterations of the Cell Cycle Regulators Cyclin D1, Cyclin A, p27, p21, p16, and pRb in Apocrine Metaplasia of the Breast
    Elayat, Ghada
    Selim, Abdel-Ghani A.
    Wells, Clive A.
    BREAST JOURNAL, 2009, 15 (05): : 475 - 482
  • [22] Expression and prognostic value of cyclin D1, cyclin E, and p21 in anal carcinomas
    Allal, AS
    Vees, H
    Gervaz, P
    Bründler, MA
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 105 - 105
  • [23] Cyclin D1与P27在口腔鳞癌的表达及意义
    张蓓
    医学理论与实践, 2013, 26 (09) : 1193 - 1194
  • [24] Structural and Functional Analysis of Cyclin D1 Reveals p27 and Substrate Inhibitor Binding Requirements
    Liu, Shu
    Bolger, Joshua K.
    Kirkland, Lindsay O.
    Premnath, Padmavathy N.
    McInnes, Campbell
    ACS CHEMICAL BIOLOGY, 2010, 5 (12) : 1169 - 1182
  • [25] Possible relationship between p27/Kip.1 and cyclin D1 degradation and the immunoproteasome in glioblastoma
    Schiffer, D
    Piccinini, M
    Anselmino, A
    Fiano, V
    Ghimenti, C
    Rinaudo, M
    NEURO-ONCOLOGY, 2005, 7 (03) : 362 - 362
  • [26] Hexachlorobenzene induces TGF-β1 expression, which is a regulator of p27 and cyclin D1 modifications
    Chiappini, Florencia
    Pontillo, Carolina
    Randi, Andrea
    Alvarez, Laura
    Kleiman de Pisarev, Diana L.
    TOXICOLOGY LETTERS, 2014, 230 (01) : 1 - 9
  • [27] Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma
    Perisanidis, Christos
    Perisanidis, Beata
    Wrba, Fritz
    Brandstetter, Anita
    El Gazzar, Sabine
    Papadogeorgakis, Nikolaos
    Seemann, Rudolf
    Ewers, Rolf
    Kyzas, Panayiotis A.
    Filipits, Martin
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2012, 41 (01) : 40 - 46
  • [28] P27 Cyclin D1在胆囊癌中的表达及意义
    王琼
    文彬
    朱治健
    黄一凡
    川北医学院学报, 2002, (01) : 3 - 5
  • [29] Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma
    Khoo, MLC
    Beasley, NJP
    Ezzat, S
    Freeman, JL
    Asa, SL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1814 - 1818
  • [30] pAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation
    Fiano, V
    Ghimenti, C
    Imarisio, S
    Silengo, L
    Schiffer, D
    ANTICANCER RESEARCH, 2004, 24 (5A) : 2643 - 2647